Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

DOI: 10.1530/eje.0.1370048
European Journal of Endocrinology, Vol 137, Issue 1, 48-52
Copyright © 1997 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rajmil, O
Right arrow Articles by de Leiva, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rajmil, O
Right arrow Articles by de Leiva, A
Articles

Melatonin concentration before and during testosterone replacement in primary hypogonadic men

O Rajmil, M Puig-Domingo, F Tortosa, M Viader, A Garcia Patterson, D Schwarzstein, and A de Leiva

Servei d'Andrologia, Fundacio Puigvert, Barcelona, Spain.

OBJECTIVE: To study circadian levels of melatonin in primary hypogonadic adult men before and after testosterone treatment. DESIGN AND METHODS: Circadian serum melatonin profiles were studied in six men with primary hypogonadism before and during testosterone substitution and compared with an age-matched control group (n = 6). RESULTS: Hypogonadal patients had higher plasma melatonin concentrations than the control group during day time (34.2 +/- 8.8 compared with 5.4 +/- 0.5 ng/l, means +/- SD; P < 0.005) and night-time (74.8 +/- 34.5 compared with 30.8 +/- 3.2 ng/l). A 3 months course of testosterone replacement treatment in the hypogonadal group was followed by a diminution of the amplified melatonin circadian rhythm, with lower mean values both during the day (34.2.8 +/- 8 compared with 12.7 +/- 2.45 ng/l, P < 0.001) and at night (74.8 +/- 34.5 compared with 41.5 +/- 13.5 ng/l, P < 0.01), and a decrease in the total area under the curve (958 +/- 318 compared with 475.5 +/- 222.9, P = 0.046). There was a significant negative correlation between melatonin (r = -0.69) and testosterone concentrations. CONCLUSIONS: These data indicate that diminished testosterone in male primary hypogonadism is associated with enhanced plasma levels of melatonin, and that testosterone substitution treatment induces a deamplification of the circadian rhythm of melatonin values in humans.


This article has been cited by other articles:


Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
D. K. Mirick and S. Davis
Melatonin as a Biomarker of Circadian Dysregulation
Cancer Epidemiol. Biomarkers Prev., December 1, 2008; 17(12): 3306 - 3313.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Caglayan, M. Ozata, G. Ozisik, M. Turan, E. Bolu, C. Oktenli, N. Arslan, K. Erbil, D. Gul, and I. C. Ozdemir
Plasma Melatonin Concentration before and during Testosterone Replacement in Klinefelter's Syndrome: Relation to Hepatic Indolamine Metabolism and Sympathoadrenal Activity
J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 738 - 743.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 European Society of Endocrinology.